课题基金 / 基金详情

Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.

Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
暴露前免疫健康及其与 SARS-COV2 血清学反应、内皮细胞弹性和心血管并发症的联系:定义高风险内型的机制基础。
批准号:
10855043
负责人:
Timothy An-thy Chan
金额:
$80.69万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2024-11-30
关键词:
2019-nCoVACE2AccelerationAccidentsAcuteAdhesionsAffectAngiotensin IIAntibody ResponseAntigen ReceptorsB-Cell ActivationBlood TestsCOVID-19COVID-19 impactCOVID-19 mortalityCOVID-19 pneumoniaCOVID-19 riskCOVID-19 severityCOVID-19 survivorsCardiacCardiac MyocytesCardiopulmonaryCardiovascular DiseasesCardiovascular systemCathepsinsCause of DeathCellsCessation of lifeChronicClinicClinicalDataDiseaseDistantDown-RegulationEconomicsEndothelial CellsEndotheliumEnrollmentFailureFibrosisFoundationsFunctional disorderFutureGene ExpressionGene Expression ProfileGene Expression ProfilingGenetic TranscriptionGlucoseGoalsHealth PersonnelHeartHeart DiseasesHeart failureHeterogeneityHumanImmuneImmune System DiseasesImmunologicsImpairmentIn VitroIndividualInfectionInfection preventionInflammationInflammatoryIntegration Host FactorsInterleukin-6InterventionKnowledgeLeft Ventricular DysfunctionLifeLinkLipoproteinsLongitudinal cohortLymphopeniaMagnetic ResonanceMaintenanceMalignant NeoplasmsMeasuresModelingMolecularMolecular ProfilingMorbidity - disease rateNatureNodalOrganOutcomePathway interactionsPatientsPermeabilityPhenotypePilot ProjectsPlasmaPublishingRecoveryResearchRiskRisk FactorsSARS-CoV-2 exposureSARS-CoV-2 infectionSARS-CoV-2 pathogenesisScanningSerologySeveritiesShapesStimulusSurvivorsSymptomsT-LymphocyteT-Lymphocyte SubsetsTNF geneTechniquesTestingTissuesToxic effectVascular Endothelial CellVentricular DysfunctionViralViral PneumoniaVirusWorkadverse outcomecardiometabolismcardiovascular disorder riskcellular resiliencecohortcoronavirus diseasecytokinecytokine release syndromecytotoxicexperimental studygain of functionhigh riskimmune activationimmune functionimmune healthimmune system functionimprovedinternational centermonocytemortalitymultidisciplinaryneutralizing antibodypermissivenesspopulation healthpreventprospectiverecruitresponsesevere COVID-19single cell sequencingthrombotictranscription factortranscriptomics

项目摘要

项目成果

Timothy An-thy Chan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract The objective of this proposal is to understand the immunologic foundations of heart disease which can occur as a result of COVID19. Cardiac impairment, when it develops is often fatal, and our hypothesis is that the maintenance of endothelial function is critical to surviving the protracted nature of COVID19 pneumonia, especially in those with reduced or delayed antibody responses. Our first aim will be to analyze those differences in immune function which pre-date infection but appear to impact the risk of fatal COVID. This will be done by enrolling those at high risk for developing COVID19 (frontline healthcare workers), and performing serially assessments of their immunologic function if they develop COVID. We will specifically investigate the mechanisms that link pre-infection inflammatory pathways to protective serologic responses and symptom severity and recovery. Our second aim will be to perform in vitro experiments to assess the requirements for endothelial cell dysfunction and infectivity. We will compare various inflammatory and cardiovascular stimuli which seem to play a role in promoting COVID19-related cardiovascular complications. Our third aim is to characterize immune cells, endothelial cells, and cardiomyocytes in heart tissue from those with COVID19-induced left ventricular dysfunction. Using single cell sequencing techniques, we will determine cellular and molecular signatures that characterize the microenvironment of the COVID19-affected heart, compared to appropriate controls. Our conceptual model is that pre-existing immune dysfunction 1) reduces the efficiency of neutralizing antibody responses, and 2) in conjunction with cardiovascular disease risk factors, induces endothelial downregulation/depletion of nodal regulators which protect against inflammatory insults. This renders endothelial cells unable to withstand COVID-specific stimuli. Once completed, this study will provide the necessary information to improve the identification of those at risk for COVID-related heart disease and develop rationale approaches to improve the improve survival in the setting of COVID.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.trsl.2021.11.005
发表时间: 2022-03
期刊: Translational research : the journal of laboratory and clinical medicine
影响因子: --
作者: [Al-Kindi S, Zidar DA]
通讯作者: Zidar DA
Crude lymphocyte levels: Can the past accelerate the future in preventive medicine?
粗淋巴细胞水平:过去能否加速预防医学的未来?
DOI: 10.1002/ajh.27125
发表时间: 2023
期刊: American journal of hematology
影响因子: 12.8
作者: [Zidar,DavidA]
通讯作者: Zidar,DavidA
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
  • 批准号:
    10746700
  • 项目类别:
  • 资助金额:
    $3.7万
  • 财政年份:
    2023
  • 负责人:
    Timothy An-thy Chan
  • 依托单位:
Project 3 Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint Blockade
  • 批准号:
    10818969
  • 项目类别:
  • 资助金额:
    $6.66万
  • 财政年份:
    2022
  • 负责人:
    Timothy An-thy Chan
  • 依托单位:
Administrative Core
  • 批准号:
    10916639
  • 项目类别:
  • 资助金额:
    $7.09万
  • 财政年份:
    2022
  • 负责人:
    Timothy An-thy Chan
  • 依托单位:
Administrative Core
  • 批准号:
    10916640
  • 项目类别:
  • 资助金额:
    $6.66万
  • 财政年份:
    2022
  • 负责人:
    Timothy An-thy Chan
  • 依托单位:
国内基金
海外基金
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
  • 批准号:
    JCZRLH202600625
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
  • 批准号:
    2026JJ50619
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    翁春艳
  • 依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介 导“肠-胰岛 ”轴血糖调控功能的降糖机制研 究
  • 批准号:
    Y24H280055
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    颜美秋
  • 依托单位: